In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with Imipenem. 2015

Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
UMR-MD1 -Transporteurs Membranaires, Chimiorésistance et Drug Design-Aix-Marseille Université et Institut de Recherche Biomédicale des Armées (IRBA), 27 Boulevard Jean Moulin, 13385 Marseille cedex 05, France.

Infections caused by multidrug resistant (MDR) bacteria are a major concern worldwide. Changes in membrane permeability, including decreased influx and/or increased efflux of antibiotics, are known as key contributors of bacterial MDR. Therefore, it is of critical importance to understand molecular mechanisms that link membrane permeability to MDR in order to design new antimicrobial strategies. In this work, we describe genotype-phenotype correlations in Enterobacter aerogenes, a clinically problematic and antibiotic resistant bacterium. To do this, series of clinical isolates have been periodically collected from two patients during chemotherapy with imipenem. The isolates exhibited different levels of resistance towards multiple classes of antibiotics, consistently with the presence or the absence of porins and efflux pumps. Transport assays were used to characterize membrane permeability defects. Simultaneous genome-wide analysis allowed the identification of putative mutations responsible for MDR. The genome of the imipenem-susceptible isolate G7 was sequenced to closure and used as a reference for comparative genomics. This approach uncovered several loci that were specifically mutated in MDR isolates and whose products are known to control membrane permeability. These were omp35 and omp36, encoding the two major porins; rob, encoding a global AraC-type transcriptional activator; cpxA, phoQ and pmrB, encoding sensor kinases of the CpxRA, PhoPQ and PmrAB two-component regulatory systems, respectively. This report provides a comprehensive analysis of membrane alterations relative to mutational steps in the evolution of MDR of a recognized nosocomial pathogen.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin
D016680 Genome, Bacterial The genetic complement of a BACTERIA as represented in its DNA. Bacterial Genome,Bacterial Genomes,Genomes, Bacterial
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA
D019143 Evolution, Molecular The process of cumulative change at the level of DNA; RNA; and PROTEINS, over successive generations. Molecular Evolution,Genetic Evolution,Evolution, Genetic
D021902 Enterobacter aerogenes Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections Aerobacter aerogenes,Klebsiella aerogenes,Klebsiella mobilis,Klebsiella mobilus

Related Publications

Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
May 1995, Enfermedades infecciosas y microbiologia clinica,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
January 1997, Journal of clinical microbiology,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
March 2000, Journal of clinical microbiology,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
June 1994, Journal of medical microbiology,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
May 2004, Biochemical and biophysical research communications,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
August 1992, FEMS microbiology letters,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
August 1993, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
January 1990, The Journal of antimicrobial chemotherapy,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
October 1991, The Journal of antimicrobial chemotherapy,
Nadège Philippe, and Laure Maigre, and Sébastien Santini, and Elizabeth Pinet, and Jean-Michel Claverie, and Anne-Véronique Davin-Régli, and Jean-Marie Pagès, and Muriel Masi
January 1993, Journal of clinical microbiology,
Copied contents to your clipboard!